Related Experiment Video
Updated: Jun 22, 2026
10:10
A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
Published on: October 5, 2015
Steps forward in LRTI and tuberculosis: update from the ERS Respiratory Infections Assembly
F Blasi1, R Cosentini, G B Migliori
1Institute of Respiratory Diseases, University of Milan, Ospedale Maggiore Fondazione IRCCS Policlinico, Milan, Italy. francesco.blasi@unimi.it
The European Respiratory Journal
|June 2, 2009
Summary
This report highlights advances in lower respiratory tract infections (LRTIs) and tuberculosis (TB). It covers viral roles in COPD exacerbations, new diagnostic biomarkers for bacterial infections, and challenges in multidrug-resistant TB.
Area of Science:
- Respiratory Medicine
- Infectious Diseases
- Clinical Research
Background:
- Lower respiratory tract infections (LRTIs) and tuberculosis (TB) are significant global health burdens.
- Advances in understanding and managing these conditions are crucial for public health.
Purpose of the Study:
- To present recent clinical and basic science advances in LRTIs and TB.
- To analyze key findings from the 18th European Respiratory Society Annual Congress.
Main Methods:
- Review and analysis of selected abstracts from the 18th European Respiratory Society Annual Congress.
- Discussion of emerging trends in LRTI and TB research.
Main Results:
- Exploration of the role of viruses in chronic obstructive pulmonary disease (COPD) exacerbations.
- Emphasis on novel biomarkers for diagnosing bacterial infections in LRTIs.
- Introduction of new diagnostic tools for latent and active TB in vulnerable populations.
- Analysis of the growing threat of multidrug-resistant and extensively drug-resistant TB.
Conclusions:
- New diagnostic and therapeutic strategies are emerging for LRTIs and TB.
- Addressing drug-resistant TB strains is a critical public health priority.
- Continued research is vital for combating respiratory infections and TB globally.
Related Concept Videos
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:25Transmission-based Precautions II: Airborne and Protective Environment
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:28Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:29Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
01:23Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...